Sign in
4

Changes in Ownership

CYTOKINETICS INC Filed Acc 0001061983-26-000002

EVP, Chief Commercial Officer sold 15,000 shares at $60.28 ($904,200)

  • EVP, Chief Commercial Officer acquired 15,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Callos Andrew · EVP, Chief Commercial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-01-05 Exercise or conversion : show line 1 in the form 10b5-1 +15,000 $23.26 $348,900 65,440 D
2026-01-05 Sale : show line 2 in the form 10b5-1 −15,000 $60.28 $904,200 50,440 D
Open-market sales · 15,000 sh · avg $60.28 · $904,200

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-01-05 Exercise or conversion : show line 3 in the form 10b5-1 Non-Qualified Stock Option (Right to Buy) −15,000 99,000 D
Loading xslF345X05/form4.xml…